Combining ReACp53 with Carboplatin to Target High-Grade Serous Ovarian Cancers

SIMPLE SUMMARY: Clinical management of ovarian cancer remains a major clinical challenge as many patients develop resistance to standard platinum-based chemotherapy drugs over time. Testing novel targeted strategies and combination therapies may open the door to new possibilities for the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Neal, Adam, Lai, Tiffany, Singh, Tanya, Rahseparian, Neela, Grogan, Tristan, Elashoff, David, Scott, Peter, Pellegrini, Matteo, Memarzadeh, Sanaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657291/
https://www.ncbi.nlm.nih.gov/pubmed/34885017
http://dx.doi.org/10.3390/cancers13235908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657291/
https://www.ncbi.nlm.nih.gov/pubmed/34885017
http://dx.doi.org/10.3390/cancers13235908

Ejemplares similares